Intensive glucose control offers no benefit after kidney transplant

11/5/2012 | Modern Medicine

Researchers found statistically similar rates of delayed graft function following kidney transplant in diabetes patients receiving intensive glucose control and a control group. The study in the Journal of Clinical Endocrinology & Metabolism also found an blood glucose target of less than 180 mg/dL was associated with a lower risk of organ rejection than targets of 70-110 mg/dL, suggesting tight glycemic control may offer no help immediately after the procedure.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX